Clinicopathological characteristics of erythroblast-rich RAEB and AML M6a in children

International Journal of Hematology

Volumn 88, Issue 5, 2009, Pages 524-529

  Honda, Yuko ^a   Manabe, Atsushi ^b   Tsuchida, Masahiro ^c   Zaike, Yuji ^d   Masunaga, Atsuko ^e   Inoue, Masami ^f   Kobayashi, Ryoji ^g   Ohtsuka, Yoshitoshi ^h   Kikuchi, Akira ⁱ   Nakahata, Tatsutoshi ^j  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b ST LUKE'S INTERNATIONAL HOSPITAL   (Japan)

^c Ibaraki Children's Hospital   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

^f RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

^g SAPPORO HOKUYU HOSPITAL   (Japan)

^h HYOGO COLLEGE OF MEDICINE   (Japan)

ⁱ SAITAMA CHILDREN'S MEDICAL CENTER   (Japan)

^j KYOTO UNIVERSITY   (Japan)

more..

Author keywords

AML M6a; Auer rods; Children; Erythroblast; Myelodysplastic syndrome; RAEB

Indexed keywords

ANTILEUKEMIC AGENT; HEMOGLOBIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ARTICLE; BONE MARROW; CANCER CHEMOTHERAPY; CANCER REGRESSION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DYSPLASIA; ERYTHROBLAST; FEMALE; HUMAN; HUMAN CELL; INFANT; LEUKOCYTE COUNT; MALE; MEAN CORPUSCULAR VOLUME; MYELOBLAST; PRESCHOOL CHILD; REFRACTORY ANEMIA WITH EXCESS BLASTS; REFRACTORY ANEMIA WITH EXCESS BLASTS IN TRANSFORMATION; RETROSPECTIVE STUDY; SCHOOL CHILD; STEM CELL TRANSPLANTATION; ALLOTRANSPLANTATION; BLOOD; CLINICAL TRIAL; GRANULOCYTE PRECURSOR; JAPAN; METABOLISM; MORTALITY; MULTICENTER STUDY; PATHOLOGY; PROSPECTIVE STUDY; REMISSION; TIME;

ADOLESCENT; ANEMIA, REFRACTORY, WITH EXCESS OF BLASTS; CHILD; CHILD, PRESCHOOL; ERYTHROBLASTS; FEMALE; GRANULOCYTE PRECURSOR CELLS; HUMANS; INFANT; JAPAN; LEUKEMIA, MYELOID, ACUTE; LEUKOCYTE COUNT; MALE; PROSPECTIVE STUDIES; REMISSION INDUCTION; STEM CELL TRANSPLANTATION; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 64249118535     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-008-0183-3     Document Type: Article

References (17)

1. JM Bennett D Catovsky MT Daniei G Flandrin DAG Galton HR Garlnick C Sultan 1982 Proposals for the classification of the myelodysplastic syndromes Br J Haematol 51 189 99 (Pubitemid 12073508)
2. NL Harris ES Jaffe J Diebold G Flandrin HK Muller-Hermelink J Vardiman 1999 The World Health Organization Classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting, Airlie House, Virginia, November, 1997 Ann Oncol 10 1419 32 10.1023/A:1008375931236 (Pubitemid 30017051)
3. H Hasle CM Niemeyer JM Chessells I Baumann JM Bennett G Kendrup DR Head 2003 A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative disease Leukemia 17 277 82 10.1038/sj.leu.2402765 (Pubitemid 36266902)
4. S Rosati J Anastasi J Vardiman 1996 Recurring diagnostic problems in the pathology of the myelodysplastic syndromes Semin Hematol 33 111 26 (Pubitemid 26128719)
5. SJ Passmore JM Chessells H Kempski I Hann PA Brownbill CA Stiller 2003 Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia in the UK: a population-based study of incidence and survival Br J Haematol 121 758 67 10.1046/j.1365-2141.2003.04361.x (Pubitemid 36718192)
6. H Sasaki A Manabe S Kojima M Tsuchida Y Hayashi K Ikuta 2001 Myelodysplastic syndrome in childhood: a retrospective study of 189 patients in Japan Leukemia 15 1713 20 (Pubitemid 33061838)
7. A Manabe 2007 Recent progress in childhood myelodysplastic syndrome Japan J Pediatr Hematol 21 141 51 (in Japanese)
8. A Manabe S Kojima 2005 Eleventh symposium on aplastic anemia and 9th symposium on myelodysplastic syndrome in children Pediatr Int 47 572 4 10.1111/j.1442-200x.2005.02122.x
9. BD Cheson PL Greenberg JM Bennett B Lowenberg PW Wijermans SD Nimer A Pinto 2006 Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia Blood 108 419 25 10.1182/blood-2005-10-4149 (Pubitemid 44061337)
10. C Strupp N Gattermann A Giagounidis A Giagounidis C Aul B Hildebrandt R Haas U Germing 2003 Refractory anemia with excess of blasts in transformation: analysis of reclassification according to the WHO proposals Leuk Res 27 397 404 10.1016/S0145-2126(02)00220-5
11. MS Willis RW Mckenna LC Peterson JE Coad SH Kroft 2005 Low blast count myeloid disorders with Auer rods: a clinicopathologic analysis of 9 cases Am J Clin Pathol 124 191 8 10.1309/WB79MFV6FCDJH2EG
12. DKH Webb G Harrison RF Stevens BG Gibson I Hann K Wheatley 2001 Relationships between age at diagnosis, clinical features, and outcome of therapy in children treated in the Medical Research Council AML 10 and 12 trials for acute myeloid leukemia Blood 98 1714 20 10.1182/blood.V98.6.1714
13. DR Barnard TA Alonzo RB Gerbing B Lange WG Woods 2007 Comparison of childhood myelodysplastic syndrome, AML FAB M6 or M7, CCG 2891: report from the children's oncology group Pediatr Blood Cancer 49 17 22 10.1002/pbc.20951 (Pubitemid 46850650)
14. C Niemeyer U Duffner C Bender-Gotze 2000 AML-intensive chemotherapy prior to stem cell transplantation (SCT) does not improve survival in children and adolescents with primary myelodysplastic sundrome (MDS) Blood 96 Suppl 1 521a abstract
15. DK Webb SJ Passmore IM Hann G Harrison K Wheatley J Chessells 2002 Results of treatment of children with refractory anaemia with excess blasts (RAEB) and RAEB in transformation (RAEBt) in Great Britain 1990-99 Br J Haematol 117 33 9 10.1046/j.1365-2141.2002.03369.x
16. S Park F Picard F Dreyfus 2002 Erythroleukemia: a need for a new definition Leukemia 16 1399 401 10.1038/sj.leu.2402549
17. S Park F Picard Z Azgui F Viguie A Merlat M Guesnu 2002 Erythroleukemia: a comparison between the previous FAB approach and the WHO classification Leuk Res 26 423 9